Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization
Mar
4
2024
USDA Seeks Comments on Petition to Deregulate Corn Developed Using Genetic Engineering Bergeson & Campbell, P.C.
Mar
4
2024
New York Attorney General Sues JBS for its Climate Claims Womble Bond Dickinson (US) LLP
Mar
4
2024
Navigating Hemp THC Beverages McDermott Will & Emery
Mar
4
2024
Alabama Supreme Court Rules Negligent Destruction of IVF Embryos May Be Treated as Wrongful Death Greenberg Traurig, LLP
Mar
1
2024
CODEX ALIMENTARIUS: Outcome of 7th Codex Committee – Spices and Culinary Herbs (CCSCH7) Keller and Heckman LLP
Mar
1
2024
European Industries Call for “Bold and Impactful” Biotechnology and Biomanufacturing Initiative Bergeson & Campbell, P.C.
Mar
1
2024
FDA Proposes Rule to Update Clinical Trial Data Monitoring McDermott Will & Emery
Mar
1
2024
EPA Announces Pollution Prevention in Action: New Webinar Series with OCSPP Bergeson & Campbell, P.C.
Mar
1
2024
Gold Dome Report - Crossover Day Wrap-Up Nelson Mullins
Mar
1
2024
FDA Finalizes Revised Medical Device Quality System Requirements, Issues Remote Regulatory Assessments Guidance McDermott Will & Emery
Mar
1
2024
FDA Announces Qualified Health Claim for Yogurt and Reduced Risk of Type 2 Diabetes Keller and Heckman LLP
Feb
29
2024
Innovation in Biotech and AI (VIDEO) Foley & Lardner LLP
Feb
29
2024
Petition Filed to Add Iso-butanol to List of Chemical Substances Subject to Superfund Excise Tax Bergeson & Campbell, P.C.
Feb
29
2024
FDA Issues Guidance for Industry on Foods Derived from Plants Produced Using Genome Editing Bergeson & Campbell, P.C.
Feb
29
2024
New York City's Health Care Price Transparency Law Takes Effect Mintz
Feb
29
2024
Weekly IRS Roundup February 19 – February 23, 2024 McDermott Will & Emery
Feb
29
2024
District Court Elucidates the Meaning of “to Induce” Under the Federal Health Care Program Anti-Kickback Statute Sheppard, Mullin, Richter & Hampton LLP
Feb
29
2024
Navigating the Regulatory Maze: Understanding the ASA Ruling re. Supreme CBD Squire Patton Boggs (US) LLP
Feb
28
2024
Federal Court Ruling Suspends Compliance with Certain Reporting Obligations Under Oregon Drug Price Transparency Program ArentFox Schiff LLP
Feb
28
2024
Library of Congress Publishes Article on South Korea’s Act on Promoting the Green Bio Industry Bergeson & Campbell, P.C.
Feb
28
2024
Senator Sanders Calls for Robust Front of Pack Labeling Requirements Keller and Heckman LLP
Feb
28
2024
Understanding the Risks Associated with Social Media Marketing Foley & Lardner LLP
Feb
27
2024
CMS Releases Part Two of Guidance for the Inflation Reduction Act’s Medicare Prescription Payment Plan Mintz
Feb
27
2024
FDA 2023-24: A Look Back & A Peek Forward Polsinelli PC
Feb
27
2024
Family Dollar Pleads Guilty to Food and Drug Adulteration Charge Keller and Heckman LLP
Feb
27
2024
FDA Releases Updated Directory on Select Dietary Supplement Ingredients Epstein Becker & Green, P.C.
Feb
27
2024
This Week in 340B: February 21 – 26, 2024 McDermott Will & Emery
Feb
27
2024
This Week in 340B: February 14 – 20, 2024 McDermott Will & Emery
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins